➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Mallinckrodt
McKesson
Dow
Harvard Business School

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

Trimethobenzamide hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for trimethobenzamide hydrochloride and what is the scope of patent protection?

Trimethobenzamide hydrochloride is the generic ingredient in three branded drugs marketed by King Pharms Llc, Lupin, Sun Pharm Industries, Par Sterile Products, Am Regent, Hospira, Smith And Nephew, Solopak, and Watson Labs, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for trimethobenzamide hydrochloride. Seven suppliers are listed for this compound.

Recent Clinical Trials for trimethobenzamide hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
PfizerPhase 1
Cape Cod Clinical Research Inc.Phase 4
ClinData Services, Inc.Phase 4

See all trimethobenzamide hydrochloride clinical trials

Pharmacology for trimethobenzamide hydrochloride
Drug ClassAntiemetic
Physiological EffectEmesis Suppression

US Patents and Regulatory Information for trimethobenzamide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride CAPSULE;ORAL 076546-001 Aug 20, 2003 AB RX No No   Start Trial   Start Trial   Start Trial
Smith And Nephew TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride INJECTABLE;INJECTION 088960-001 Apr 4, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Par Sterile Products TIGAN trimethobenzamide hydrochloride INJECTABLE;INJECTION 017530-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
Smith And Nephew TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride INJECTABLE;INJECTION 089043-001 Apr 4, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Am Regent TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE trimethobenzamide hydrochloride INJECTABLE;INJECTION 091329-001 Mar 8, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride INJECTABLE;INJECTION 088804-001 Apr 3, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Solopak TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride INJECTABLE;INJECTION 089094-001 Apr 4, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Medtronic
McKinsey
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.